1. Home
  2. CGEM vs CCB Comparison

CGEM vs CCB Comparison

Compare CGEM & CCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • CCB
  • Stock Information
  • Founded
  • CGEM 2016
  • CCB 1997
  • Country
  • CGEM United States
  • CCB United States
  • Employees
  • CGEM N/A
  • CCB N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • CCB Major Banks
  • Sector
  • CGEM Health Care
  • CCB Finance
  • Exchange
  • CGEM Nasdaq
  • CCB Nasdaq
  • Market Cap
  • CGEM 437.2M
  • CCB 1.8B
  • IPO Year
  • CGEM 2021
  • CCB 2018
  • Fundamental
  • Price
  • CGEM $7.86
  • CCB $102.15
  • Analyst Decision
  • CGEM Strong Buy
  • CCB Strong Buy
  • Analyst Count
  • CGEM 7
  • CCB 4
  • Target Price
  • CGEM $26.00
  • CCB $113.75
  • AVG Volume (30 Days)
  • CGEM 1.4M
  • CCB 127.2K
  • Earning Date
  • CGEM 11-06-2025
  • CCB 10-27-2025
  • Dividend Yield
  • CGEM N/A
  • CCB N/A
  • EPS Growth
  • CGEM N/A
  • CCB 18.14
  • EPS
  • CGEM N/A
  • CCB 3.25
  • Revenue
  • CGEM N/A
  • CCB $336,394,000.00
  • Revenue This Year
  • CGEM N/A
  • CCB $83.27
  • Revenue Next Year
  • CGEM N/A
  • CCB $35.03
  • P/E Ratio
  • CGEM N/A
  • CCB $31.38
  • Revenue Growth
  • CGEM N/A
  • CCB 28.83
  • 52 Week Low
  • CGEM $5.68
  • CCB $58.41
  • 52 Week High
  • CGEM $17.90
  • CCB $119.22
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 61.13
  • CCB 40.53
  • Support Level
  • CGEM $7.22
  • CCB $98.80
  • Resistance Level
  • CGEM $9.24
  • CCB $110.63
  • Average True Range (ATR)
  • CGEM 0.51
  • CCB 4.73
  • MACD
  • CGEM 0.29
  • CCB -1.24
  • Stochastic Oscillator
  • CGEM 62.03
  • CCB 17.34

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.

Share on Social Networks: